Insomnia Market Expected to Reach $5,488 Million, globally, by 2023 with key players Merck & Co. Inc., Sanofi India Limited, Pfizer, Inc., Takeda Pharmaceutical Company Ltd., Purdue Pharmaceuticals L.P., Eisai, Co. Ltd., Meda Consumer Healthcare Inc., Per

According to a new report published by Allied Market Research, titled, Insomnia Market by Therapy Type and Geography: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global insomnia market accounted for $4,093 million in 2016, and is estimated to reach $5,488 million by 2023, registering a CAGR of 4.2% from 2017 to 2023. North America was the highest contributor in the insomnia market in 2016; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period.

Insomnia is a sleep disorder where in people have problem in falling asleep or remaining asleep. The major causes of insomnia include high stress level, mental disorders, excessive consumptions of caffeine & alcohol, and other medical conditions. Insomnia is categorized into three types depending on the duration of the disorder, namely transient (few days), acute (few weeks), and chronic insomnia (few months or even years).

Get sample copy of this report at:
https://www.alliedmarketresearch.com/request-sample/2373

In 2016, North America accounted for the maximum contribution to the total revenue generated, owing to the high prevalence rate of insomnia, presence of high disposable income, and high demand for over-the-counter (OTC) drugs. In addition, the presence of large number of insomnia centers in this region and rise in the number of patients with chronic renal & kidney diseases are expected to boost the market growth. However, Asia-Pacific is expected to witness the highest CAGR during the study period, owing to increase in the number of people working at odd hours, rise in incidence rate of insomnia, and growth in disposable income.

Key Findings of the Insomnia Market:

• The cognitive behavioral therapy segment is anticipated to grow at the highest rate during the analysis period.

• The prescription drugs segment generated the highest revenue, and is expected to continue its dominance in the near future.

• North America dominated the global insomnia market, and is anticipated to continue its dominance in the future.

• China is expected to grow at highest CAGR in the Asia-Pacific.

• The pharmacological therapy segment was the largest contributor to the market growth, in 2016.

he pharmacological therapy segment is the highest contributor to the market growth. The non-pharmacological therapy segment is anticipated to be lucrative for market players, as these therapies cause fewer side effects as compared to drugs.

Get customized report at:
https://www.alliedmarketresearch.com/request-for-customization/2373

Key players:

• Merck & Co. Inc.
• Sanofi India Limited
• PfizerInc.
• Takeda Pharmaceutical Company Ltd.
• Purdue Pharmaceuticals L.P.
• Eisai Co. Ltd.
• Meda Consumer Healthcare Inc.
• Pernix Therapeutics
• Vanda Pharmaceuticals
• ECR Pharmaceuticals.

Table of content:


Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTER’S FIVE FORCES ANALYSIS
3.4. REGULATION AND REIMBURSEMENT SCENARIO
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Emergence of therapeutics with fewer side-effects
3.5.1.2. Rise in demand for OTC sleep aids
3.5.1.3. Stressful work condition and working in shifts

3.5.2. Restraints

3.5.2.1. Side Effects of Drugs
3.5.2.2. Rise in number of patent expiration of branded prescription drugs

3.5.3. Opportunities

3.5.3.1. Untapped Markets in Developing Economies
3.5.3.2. Presence of Large Undiagnosed Insomnia Population Pool

Access full summary at: https://www.alliedmarketresearch.com/insomnia-market

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Deep Joshi
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.